TC2N transcription was significantly higher in cholangiocarcinoma (CHOL), ovarian serous cystadenocarcinoma (OV), rectal adenocarcinoma (READ), stomach adenocarcinoma (STAD) and thymoma (THYM) (Figure 1A, Figure 1B). The gene discussed is TC2N; the disease is gastric adenocarcinoma.